Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy

OBJECTIVE: Few data describe antiretroviral treatment (ART)-related adverse events when treatment is initiated at CD4(+) cell counts more than 350 cells/μl. We compared rates of laboratory-defined adverse events (LDAEs) according to CD4(+) cell count at ART initiation. DESIGN: Analysis of on-going c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jose, Sophie, Quinn, Killian, Hill, Teresa, Leen, Clifford, Walsh, John, Hay, Phillip, Fisher, Martin, Post, Frank, Nelson, Mark, Gompels, Mark, Johnson, Margaret, Chadwick, David, Gilson, Richard, Sabin, Caroline, Fidler, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Clinical Science: Concise Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032216/
https://www.ncbi.nlm.nih.gov/pubmed/24583670
http://dx.doi.org/10.1097/QAD.0000000000000242

Ejemplares similares

Ejemplares similares